[Bronchial reversibility in the patients with bronchiectasis]

Seher Sevgili1, H Canan Hasanoğlu, Ayşegül Karalezli

  • 1Batman State Hospital, Batman, Turkey.

Tuberkuloz Ve Toraks
|June 18, 2009
PubMed

Insights

Childhood pulmonary infections can lead to bronchiectasis, often misdiagnosed as asthma due to bronchial obstruction. This study reveals significant bronchial reversibility in bronchiectasis patients, highlighting the need for accurate differential diagnosis beyond spirometry.

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Diagnostics

Context:

  • Childhood pulmonary infections are a significant risk factor for developing bronchiectasis.
  • Bronchiectasis diagnosis can be challenging, often confused with asthma due to shared symptoms like bronchial obstruction.
  • Misdiagnosis can lead to prolonged, incorrect asthma treatment for bronchiectasis patients.

Purpose:

  • To investigate the presence and extent of obstructive patterns and bronchial reversibility in patients with bronchiectasis.
  • To differentiate bronchiectasis from asthma by evaluating spirometry parameters, including forced expiratory volume in 1 second (FEV1) and forced expiratory flow rate (FEF25-75%).
  • To assess the utility of spirometry and reversibility testing in the differential diagnosis of bronchiectasis.

Summary:

  • The study included 107 bronchiectasis patients and 40 healthy controls, assessing pulmonary function via spirometry, lung volumes, and diffusion capacity.
  • A significant proportion of bronchiectasis patients exhibited obstructive (72.90%) or mixed (24.30%) pulmonary function patterns.
  • Bronchial reversibility was frequently observed in bronchiectasis patients, with positive reversibility noted in 36.45% for FEV1 and 58.9% for FEF25-75%, compared to 0% in controls.

Impact:

  • Demonstrates that bronchial reversibility is a common finding in bronchiectasis, complicating its differentiation from asthma based solely on spirometry.
  • Emphasizes the critical need for integrating radiological findings, such as high-resolution computed tomography (HRCT) scans, with spirometry for accurate differential diagnosis.
  • Highlights the potential for improved diagnostic accuracy and timely, appropriate treatment for bronchiectasis by distinguishing it from asthma.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
The Bronchial Tree01:23

The Bronchial Tree

The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...